Activity

The First Leukemia Gene Therapy, CTL019, Has Been Developed And May be Approved By The FDA For Folks Aged 3-25 Yrs. CTL019 Works By Engineering Millions Of Extracted T-Cells, Into Serial Killers, To Kill Leukemic Cells. And Guess What Is Used In Engineering The T-Cells In 22 Days: Disabled HIV Virus. Awesome!

F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment – The New York Times

https://www.nytimes.com/2017/07/12/health/fda-novartis-leukemia-gene-medicine.html

If accepted, which is likely, it will be the first gene therapy ever to reach the market. “This is the beginning of something big,” a doctor said.